Human chorionic gonadotropin (HCG) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Human chorionic gonadotropin (HCG) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Hormones diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-188-11. BSA-Human chorionic gonadotropin (HCG)
2. Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody
$2709.00
GMP-SMT-188-21. OVA-Human chorionic gonadotropin (HCG)
2. Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody
$2709.00
GMP-SMT-188-31. BSA-Human chorionic gonadotropin (HCG)
2. Anti-Human chorionic gonadotropin (HCG) human monoclonal antibody
$2709.00
GMP-SMT-188-41. OVA-Human chorionic gonadotropin (HCG)
2. Anti-Human chorionic gonadotropin (HCG) human monoclonal antibody
$2709.00
GMP-SMT-188-Ag-1BSA-Human chorionic gonadotropin (HCG)$756.00
GMP-SMT-188-Ag-2OVA-Human chorionic gonadotropin (HCG)$756.00
GMP-SMT-188-Ab-1Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody$1953.00
GMP-SMT-188-Ab-2Anti-Human chorionic gonadotropin (HCG) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Human chorionic gonadotropin (HCG)

Cat No.GMP-SMT-188-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Human chorionic gonadotropin (HCG) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Human chorionic gonadotropin (HCG) had been validated with our anti-Hapten antibody Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Human chorionic gonadotropin (HCG)

Cat No.GMP-SMT-188-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Human chorionic gonadotropin (HCG) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Human chorionic gonadotropin (HCG) had been validated with our anti-Hapten antibody Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Human chorionic gonadotropin (HCG) mouse monoclonal antibody

Cat No.GMP-SMT-188-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Human chorionic gonadotropin (HCG) had been validated with our hapten hapten-carrier conjugates BSA-Human chorionic gonadotropin (HCG) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Human chorionic gonadotropin (HCG) human monoclonal antibody

Cat No.GMP-SMT-188-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Human chorionic gonadotropin (HCG) had been validated with our hapten hapten-carrier conjugates BSA-Human chorionic gonadotropin (HCG) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Human Chorionic Gonadotropin (HCG) in In Vitro Diagnosis:

    Human Chorionic Gonadotropin (HCG) is a hormone that assumes a pivotal role in reproductive physiology, primarily recognized for its association with pregnancy. HCG is produced by the trophoblast cells of the placenta shortly after embryo implantation, making it one of the earliest markers of pregnancy. In the context of in vitro diagnosis, HCG stands as an indispensable biomarker for detecting and confirming pregnancy. Its presence, reliably detectable in the blood or urine of pregnant individuals, serves as a definitive indicator of successful embryo implantation and the initiation of pregnancy-related physiological processes.

    Role in In Vitro Diagnosis:

    - Pregnancy Testing: HCG is the cornerstone of pregnancy tests, encompassing laboratory-based assays and over-the-counter (OTC) home pregnancy tests. These diagnostic methods rely on the precise detection of HCG levels in urine or blood samples. The presence of HCG unequivocally confirms pregnancy, providing individuals and healthcare providers with conclusive evidence of conception.

    - Early Pregnancy Detection: HCG is particularly renowned for its early responsiveness. Its levels start to rise shortly after embryo implantation, often before the onset of overt clinical symptoms. This early detection capability is instrumental in facilitating timely medical care, enabling expectant parents to initiate prenatal care, and affording them the opportunity to make informed decisions about their pregnancy.

    - Monitoring Pregnancy Progress: Throughout the course of pregnancy, HCG levels exhibit a characteristic pattern of increase, with peak levels typically occurring during the first trimester. Healthcare providers utilize serial HCG measurements during prenatal care to ensure that the pregnancy is progressing as expected. Deviations from expected HCG patterns can signal potential complications.

    - Assessing Ectopic Pregnancy: Anomalous HCG patterns may be indicative of ectopic pregnancies, a high-risk condition where the embryo implants outside the uterus. Early detection of ectopic pregnancies is critical for prompt medical intervention, as they can pose a serious threat to maternal health.

    - Fertility Assessment: Beyond its role in pregnancy detection, HCG measurements also find utility in assessing fertility and ovulation. This application is valuable for individuals and healthcare providers seeking to understand fertility cycles and optimize the timing of conception attempts.

    2. Why Measure Human Chorionic Gonadotropin (HCG)?

    The measurement of Human Chorionic Gonadotropin (HCG) in the realm of in vitro diagnosis is underpinned by a constellation of compelling imperatives:

    a. Pregnancy Confirmation: HCG quantification serves as the definitive method for confirming pregnancy. It offers unwavering assurance to individuals and healthcare practitioners, allowing them to make informed decisions regarding prenatal care and family planning.

    b. Early Detection: One of HCG's most distinctive attributes is its early responsiveness. It begins to rise shortly after embryo implantation, enabling the detection of pregnancy before overt clinical symptoms manifest. Early detection is vital for timely medical care and emotional preparedness.

    c. Monitoring Pregnancy Progress: HCG levels follow a characteristic pattern of increase throughout pregnancy. Healthcare providers utilize these measurements to ensure that the pregnancy is progressing as expected. Anomalies in HCG levels can signal potential complications, prompting timely interventions.

    d. Ectopic Pregnancy Identification: Deviations from the expected HCG trajectory can raise suspicion of ectopic pregnancies. Timely detection and management of ectopic pregnancies are critical for safeguarding maternal health, making HCG measurements a crucial diagnostic tool.

    e. Fertility Insights: HCG measurements are not limited to pregnancy; they also offer insights into fertility and ovulation. This application assists individuals and healthcare providers in understanding fertility cycles and optimizing the timing of conception attempts.

    In summation, the measurement of Human Chorionic Gonadotropin (HCG) in the realm of in vitro diagnosis assumes paramount importance for confirming and detecting pregnancy, enabling early detection, monitoring pregnancy progress, identifying potential complications, and facilitating fertility assessment. This hormone's multifaceted role underscores its indispensability within the domain of reproductive health and family planning, empowering individuals and healthcare providers to make well-informed decisions and ensuring optimal prenatal care.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.